## Does Palisades Have a Restart Date Yet?

No. [Holtec International](https://smrintel.com/companies/holtec-international) confirmed last week that the Palisades nuclear power plant in Covert, Michigan has completed its major restart projects — including turbine generator refurbishment and installation of a new fuel handling machine — but more than 5,000 individual work activities remain on the plant's checklist before fuel load can begin. No firm restart date has been announced. The February 2026 target the company had previously cited passed without a restart. Holtec CEO Kris Singh told the Financial Times he expects Palisades to restart in 2026, ahead of a contract to supply power by March 2027. Separately, a U.S. District Court dismissed an environmental coalition's lawsuit seeking to block the restart, clearing a significant legal hurdle. Holtec is also reportedly planning an IPO that multiple news outlets have valued at $10 billion, and Singh has discussed siting two SMR-300 reactors at Palisades with a target power production date of 2031.

---

## Major Projects Complete, But 5,000 Tasks Remain

Holtec described the close-out of its large-scale restart work as a "watershed moment." The completed major projects include:

- Placing the plant's **turbine generator on a turning gear** following extensive inspections, maintenance, testing, and refurbishment
- Installation and testing of a **new fuel handling machine**
- Reactor vessel inspections and replacement of reactor head penetrations
- Primary system chemical decontamination and passivation
- Steam generator tube refurbishment and secondary-side cleaning
- Fuel receipt and inspection
- Operator training and requalification
- Numerous equipment upgrades and modernization projects

New fuel is confirmed to be on-site and ready for loading into the reactor core.

What remains is a long tail of operational readiness work. Holtec reports more than 5,000 individual activities — routine maintenance, testing, and inspection tasks — still on the checklist. The company has reorganized its management structure around an Operations Command Center (OCC) and dedicated coordination teams to drive these items to completion.

"Our focus remains on safely completing the remaining work required as we prepare for fuel load," said Jason Stairs, lead OCC shift outage manager.

The distinction Holtec is drawing — between major capital projects and routine readiness tasks — is real but should be read cautiously. Five thousand remaining line items represents substantial execution risk, particularly for a plant that last operated in 2022 and is attempting something with no precedent in U.S. nuclear history: restarting a permanently decommissioned plant.

---

## The Missed Timeline Problem

Holtec's credibility on scheduling is under pressure. An update published earlier this year projected Palisades would reconnect to the grid by the end of February 2026. That date passed without a restart. The company's current posture — restart "when the plant is ready for long-term operations" — is a deliberate retreat from specific commitments.

Singh's statement to the Financial Times that he expects a restart in 2026 ahead of a March 2027 power supply contract gives investors and counterparties a working assumption, but it carries the same caveat that has haunted every prior projection: no NRC-confirmed milestone or internal schedule has been made public to underpin that expectation.

For the nuclear industry, this matters beyond Palisades. The plant is positioned to become the first in U.S. history to return to commercial operation following a permanent shutdown — a proof-of-concept with implications for aging fleet preservation nationwide. Every schedule slip erodes the political and commercial case for similar restart efforts at other prematurely closed plants.

---

## Lawsuit Dismissed: Environmental Challenge Fails

The U.S. District Court for the Western District of Michigan dismissed a November lawsuit filed by three environmental groups seeking to block the Palisades restart. The plaintiffs had challenged the NRC's decision to exempt Palisades from a rule barring a decommissioned nuclear plant from restarting.

The court found that the Atomic Energy Act and the Hobbs Act vest review authority over NRC exemption decisions in the U.S. Court of Appeals — and the Court of Appeals had already reviewed the NRC's June 2025 exemption decision.

"We are pleased that the court left in place the NRC's exemption decision, which will allow the Palisades plant to move forward toward restart," said Principal Deputy Assistant Attorney General Adam Gustafson.

The dismissal removes what had been a live litigation risk. The NRC exemption that allowed Palisades to pursue restart despite its decommissioned status now stands on reviewed legal ground. For Holtec's IPO narrative and its power purchase agreement counterparties, that legal clarity is material.

---

## Holtec IPO and SMR-300 Plans at Palisades

Singh disclosed in the Financial Times interview that Holtec plans to announce an IPO imminently. Multiple news outlets have reported a potential valuation of $10 billion — though no prospectus figures have been published and that number should be treated as a market estimate, not a confirmed figure.

Singh also discussed plans to site two [SMR-300](https://smrintel.com/companies/holtec-international) reactors at the Palisades location, with a target of both units producing power by 2031. The NRC is already preparing an environmental impact statement for the SMR-300 application at that site.

The combination of a Palisades restart, an SMR-300 new-build program, and a pending IPO makes Holtec one of the most consequential single actors in U.S. nuclear right now. It also concentrates significant execution risk in one organization. A restart delay that bleeds into 2027 or beyond would test investor appetite for the IPO and raise harder questions about the SMR-300 timeline — which itself would be a [first of a kind (FOAK)](https://smrintel.com/glossary/foak) deployment in the United States.

---

## Industry Implications

The Palisades trajectory is being watched closely across the nuclear sector for two distinct reasons:

**Restart precedent.** If Palisades succeeds, it validates a policy framework under which other prematurely shuttered plants — and there are several — could re-enter the regulatory pipeline. The NRC exemption mechanism, now court-affirmed, provides a legal pathway. The harder constraint is technical: each plant that shut down faces unique degradation profiles, workforce reconstitution challenges, and equipment obsolescence.

**SMR market signal.** Singh's 2031 target for two SMR-300 units at Palisades is aggressive by any benchmark. The SMR-300 has not yet received [NRC design certification](https://smrintel.com/glossary/design-certification). Completing design certification, securing a construction permit, and building two units in roughly five years would require a regulatory and supply chain execution pace that no advanced reactor developer in the U.S. has yet demonstrated. The IPO will force Holtec to put public numbers behind those commitments.

---

## Key Takeaways

- Palisades has completed all major restart projects, including turbine generator refurbishment and fuel handling machine installation; new fuel is on-site
- More than 5,000 individual work activities — routine maintenance, testing, and inspection tasks — remain before fuel load
- No firm restart date has been announced; an earlier February 2026 target was missed
- CEO Kris Singh told the Financial Times he expects a 2026 restart, ahead of a March 2027 power supply contract
- A U.S. District Court dismissed an environmental coalition lawsuit challenging the NRC's restart exemption decision; the June 2025 exemption stands
- Holtec is reportedly planning an IPO reportedly valued by multiple outlets at $10 billion
- Singh disclosed plans for two SMR-300 reactors at the Palisades site, targeting power production by 2031
- Palisades remains positioned to become the first U.S. plant to restart after permanent shutdown — a precedent with broad fleet implications

---

## Frequently Asked Questions

**When will Palisades restart?**
No firm date has been confirmed. Holtec CEO Kris Singh told the Financial Times he expects a 2026 restart ahead of a March 2027 power supply contract. A previously cited February 2026 target was not met. The company says the plant will restart when all restart work is complete and all federal requirements and industry standards are met.

**How many tasks remain before Palisades can restart?**
Holtec reports more than 5,000 individual work activities remain on the checklist. The company characterizes these as routine maintenance, testing, inspection, and operational readiness tasks, distinct from the major capital projects that have now been completed.

**What was the environmental lawsuit about and what happened to it?**
Three environmental groups sued in November to block the restart, challenging the NRC's decision to exempt Palisades from a rule that prevents decommissioned plants from restarting. The U.S. District Court for the Western District of Michigan dismissed the lawsuit, finding that the U.S. Court of Appeals — which had already reviewed the NRC's June 2025 exemption decision — holds jurisdiction over such challenges.

**What is the Holtec IPO, and how does it relate to Palisades?**
Holtec founder and CEO Kris Singh disclosed plans to announce an IPO in a Financial Times interview. Multiple news outlets have reported a potential valuation of $10 billion. The IPO is expected to encompass Holtec's broader portfolio, including the Palisades restart and the SMR-300 development program.

**What are the SMR-300 plans for the Palisades site?**
Singh told the Financial Times that Holtec plans to site two SMR-300 reactors at Palisades, with a target of both units producing power by 2031. The NRC is currently preparing an environmental impact statement for the application. The SMR-300 has not yet received NRC design certification.